OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Tae-Wan Kim

3 Projects | 1 Researchers | $375,000 Invested

2013

Trustees of Columbia University in the City of New York

Tae-Wan Kim, PhD

Screening for small molecule modulators of tau in stem cell-derived primary neurons

  • Funding Amount: $150,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2011

Trustees of Columbia University in the City of New York

Tae-Wan Kim, PhD

Development of screening assays for tauopathy in stem-cell derived neurons

  • Funding Amount: $125,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2009

Trustees of Columbia University in the City of New York

Tae-Wan Kim, PhD

Screening for small molecule agonists of phosphatidylinositol 4-kinase

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed